Magdalena B. J.
- Country
- Poland
- Department
- N/A
Research Overview
- A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
- Phase III Randomized Double‑Blind Study of Fenebrutinib versus Teriflunomide for Efficacy and Safety in Adults with Relapsing Multiple Sclerosis
- Oral semaglutide versus placebo in early Alzheimer’s disease: a randomized double-blind trial in patients with mild cognitive impairment or mild dementia
Data & Insights
Has run more than one trial at 379 of 735 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in treating Alzheimer's disease, focusing on both early-stage cognitive impairment and more advanced manifestations. Their research encompasses therapeutic approaches for mild cognitive impairment (MCI) and the management of agitation in dementia patients.
- Early Alzheimer's Disease Management
- Cognitive Function Assessment
- Behavioral Symptoms in Dementia
Headache Disorders
Primary expertise lies in treating various forms of migraine conditions, including investigation of preventive and acute treatments. The investigator has particular interest in menstrual migraine and chronic migraine management, with experience in both adult and pediatric populations.
- Chronic and Episodic Migraine
- Preventive Migraine Therapy
- Treatment-Resistant Migraine
Neurological Conditions
The investigator focuses on multiple neurological disorders including relapsing multiple sclerosis, diabetic peripheral neuropathic pain, and dyskinesia due to cerebral palsy. Their work extends to chronic pain management, particularly chronic non-specific low back pain.
- Movement Disorders
- Neuropathic Pain
- Multiple Sclerosis Treatment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.